Fingerprint
Dive into the research topics where Yagmur Sisman is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Clinical Characteristics and Survival of Ovarian Cancer Patients According to Homologous Recombination Deficiency Status
Sisman, Y., Schejbel, L., Schnack, T. H., Høgdall, C. & Høgdall, E., 12 May 2025, In: Cancers. 17, 10, 1628.Research output: Contribution to journal › Journal article › Research › peer-review
1 Citation (Scopus) -
Ovarian Cancer in the Era of Precision Surgery and Targeted Therapies
Sisman, Y., Poulsen, T. S., Schnack, T. H., Høgdall, C. & Høgdall, E., 18 Oct 2025, In: Cancers. 17, 20, 3371.Research output: Contribution to journal › Journal article › Research › peer-review
-
Potential targeted therapies for ovarian cancer beyond PARP inhibitors
Sisman, Y., Hogdall, D., Schnack, T. H., Hogdall, C. & Hogdall, E., Mar 2025, In: European journal of gynaecological oncology. 46, 3, p. 1-7 7 p.Research output: Contribution to journal › Review › peer-review
-
Organoids and epithelial ovarian cancer - a future tool for personalized treatment decisions? (Review)
Sisman, Y., Schnack, T., Høgdall, E. & Høgdall, C., Feb 2022, In: Molecular and Clinical Oncology. 16, 2, p. 29 29.Research output: Contribution to journal › Review › peer-review
3 Citations (Scopus) -
Potential Targeted Therapies in Ovarian Cancer
Sisman, Y., Vestergaard, L. K., de Oliveira, D. N. P., Poulsen, T. S., Schnack, T. H., Høgdall, C. & Høgdall, E., 26 Oct 2022, In: Pharmaceuticals (Basel, Switzerland). 15, 11, 1324.Research output: Contribution to journal › Journal article › Research › peer-review
4 Citations (Scopus)